Share Name Share Symbol Market Type Share ISIN Share Description
Deltex Medical Group Plc LSE:DEMG London Ordinary Share GB0059337583 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.0% 1.125 1.05 1.20 1.125 1.125 1.13 923,635 08:00:00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Health Care Equipment & Services 5.0 -1.3 -0.3 - 6

Deltex Medical Share Discussion Threads

Showing 20676 to 20700 of 20875 messages
Chat Pages: 835  834  833  832  831  830  829  828  827  826  825  824  Older
DateSubjectAuthorDiscuss
23/9/2019
15:05
Sorry I hadn’t even seen the announcement today! So £37,500 in total.... And from all we know the company is ridiculously undervalued!
nobbygnome
23/9/2019
14:27
Hi Nobby you do try hard!! I realise this is the last of 3 tranches, from today, early Sept & late Aug, but then again you knew what I meant!
gbenson1
23/9/2019
14:20
>> gbenson Two lots of £12500 so £25k in total.
nobbygnome
23/9/2019
14:19
So schloo you are expecting the company to be taken over before February next year? If that is true, it’s looking ridiculously undervalued going by the Cheetah acquisition price. It’s got to be a strong buy at this level IMHO....
nobbygnome
23/9/2019
14:08
They will move in time - small companies rarely move much on results day unless with a big surprise, especially if mostly held by PIs
mrc2u
23/9/2019
13:32
Interims as expected, options just bought for £12,000 so a little more money in the coffers, I'm really disappointed at the appetite for shares so far today, are we going to have to wait for the finals in Mar 2020 for any real uptick in the Sp?
gbenson1
23/9/2019
13:18
My hope & expectation is for an exit long before Feb 2021 - indeed, I think before Feb 2020 is on the cards
schloo
23/9/2019
11:17
schloo Re operating cash £73k in 1H accounts and ignoring other working cap movements as will balance out over time BUT you do need to include interest of £69k and capitalised dev expenditure of £138k which won't go away I assume. Not expecting a fundraising for operational reasons in next 12 months as underlying burn reduced to £0.5m/annum (my calc) or less and they have some one off income in addition to £0.6m in bank. However, if they want to grow they need to invest CLNs £1.1m not due until Feb 2021
dj trading
23/9/2019
10:54
>>DJ Trading Two different questions re cash 1. Do they need to raise any more? Clearly not 2. Are they operating cash positive? I think they are, albeit marginally, and are well on track to do so for the year with additional sales to distributors at end of year. If you look at the operating cash before working capital movements, it was £73,000 positive (£12,000 a month): crucially this is £942,000 (£157,000 a month) better than in the first six months last year Re the competitor "being very nice", suggest you dyor to understand the point, but happy to explain if you need me to
schloo
23/9/2019
10:18
Schloo - re underlying cash burn Everything you have mentioned above is a one off not underlying! Contract termination 0.2m, grants and option exercise (aka fundraising/dilution at 1p!) You need to look at other working capital movements to see the real story Re your earlier comment "DJ Trading - You are forgetting that the reduction in debtors is mostly offset by a reduction in short term borrowings (an invoice discounting facility) of an average of £47k/month" No I haven't the cash gain of 20k/month includes this as I always quote "Monthly cash burn -(Movement in cash balance + financing)" and the "Outflow from decrease in invoice discounting facility of £281k is included in financing in cash flow in the statement" So I stick with my earlier calc that cash gen of 20k/month less other movements in working cap of 61k/month in H1 gives an underlying H1 outflow of £41k/month circa £0.5m/year And "Schloo one of the most likely buyers is being very nice to them indeed with a $0.25m payment in H2" Since when has terminating a profitable contract been "being very nice" presumably somebody else will get the benefit and perhaps sell more? DJT
dj trading
23/9/2019
09:47
>>schloo Doh! I typed the wrong address twice! Sent now...
nobbygnome
23/9/2019
09:39
>>Nobbygnome Not got anything >>DJ Trading Buyers are far more likely after the Cheetah deal, especially as DEMG has a fully approved direct competitor technology to Cheetah's on its platform already; one of the most likely buyers is being very nice to them indeed with a $0.25m payment in H2; your underlying cash burn number is wildly over done: looks like they are averaging £10,000 to £20,000 a month positive going into stronger second half with grants, $0.25m termination bonus as well as option exercise cash to come; the third party product will have been set up at a 40% margin for DEMG as distributor but this will have fallen to closer to 20% post Brexit referendum sterling devaluation - call it 30% or £120,000 gross margin a year and they are about to get compensated for nearly two years loss of margin while saving all the direct and indirect overhead; they are also getting grants towards new products and a new monitor will given them a whole new revenue stream as they haven't been selling the 20 year old model for some time now dyor
schloo
23/9/2019
08:49
Nobby - Yes they have done the right thing taking out costs - they had no choice! But annual Revenue has fallen to circa £4m and underlying cash burn is still nearly £0.5m/annum so they still have more to do. I can't see how they are going to increase Revenue having not managed to do it with a bloated sales force and lots of supporting evidence about the product. I hope they can turn things around but I just can't see how and if a buyer was interested I think they would have made a move before now imo
dj trading
23/9/2019
08:43
>>schloo Just sent you an email....
nobbygnome
23/9/2019
08:42
Increasing gross margins from 68% to 76% partly by increasing US prices is a positive.
janatha
23/9/2019
08:41
>> DJ You are talking semantics. Do you agree the business is now stable and has the chance to grow albeit slowly?
nobbygnome
23/9/2019
08:36
"Nobbygnome23 >> DJ Getting rid of non profitable turnover and freeing up reps to be more productive is a good thing IMHO. You comments are disingenuous..." The contract was profitable even with the "fully-loaded expenses associated with selling and supporting this equipment" they say "not significantly profitable" Re "Your comments are disingenuous" perhaps, but yours are incorrect "non profitable turnover"! So a small reduction in profit but a much larger loss of GM and those costs will either have to generate more Revenue or be taken out to maintain profitability/cash flow and not much sign of an imminent increase in revenue to replace the loss of this contract imo
dj trading
23/9/2019
08:36
DJ Trading You are forgetting that the reduction in debtors is mostly offset by a reduction in short term borrowings (an invoice discounting facility) of an average of £47k/month Key point is that DEMG does not need to raise more capital so price should correct. Note that Cheetah was still burning cash when bought at a value equivalent to at least 10 times current DEMG within the last fortnight
schloo
23/9/2019
08:27
"Nobbygnome23 Sep '19 - 09:06 - 10382 of 10385 Cash flow positive not profitable! Cash is the most important aspect as that means we won’t have further fund raisings. What we want is a stable organically growing (albeit slowly) business....and now have IMHO." Agree cash most important as I have been saying for years! But cash gen of £20k/month in 1H mainly attributable to other movements in working capital as I said in my table above "beneficial move of other working cap items - stock/debtors and creditors of £61k/month" so an adjusted monthly burn of around £40k/month dyor
dj trading
23/9/2019
08:27
DJ Trading, Nobbygnome Despite your different tones, I suspect you are both broadly right The $250,000 payment expected before year end seems like a very generous settlement designed to keep DEMG sweet. Any thoughts as to who is making this payment?
schloo
23/9/2019
08:25
>> DJ Getting rid of non profitable turnover and freeing up reps to be more productive is a good thing IMHO. You comments are disingenuous...
nobbygnome
23/9/2019
08:21
Are you seriously saying that a trade this morning for 0.0001% of the company and £81.11 means anything?DEMG is cash positive, profitable and worth at least two or three times its current valuation
mrc2u
23/9/2019
08:21
And I guess the real question is what is the company worth to a potential acquirer! It seems clear to me that the recent process of improving the balance sheet is all about looking to be bought. Yes it probably won’t happen in the short term but that is the inevitable outcome here at some point in the not too distant future IMHO.
nobbygnome
23/9/2019
08:19
From 1H report "Deltex Medical has, for a number of years, distributed into the UK market complementary products manufactured by third-party companies. One of these companies, which manufactures pulse oximetry equipment, was recently purchased by a competitor. Negotiations have recently concluded in respect of the termination of Deltex Medical's UK distribution contract relating to this equipment which is expected to give rise to, among other things, the payment to the Group of US$0.25 million before the year-end. In 2018, the revenues associated with this third-party equipment totalled £0.4 million; however, once an estimate of the 2018 fully-loaded expenses associated with selling and supporting this equipment are deducted from the 2018 gross margin generated by such sales, the product line was not significantly profitable" So they will have to further reduce "expenses associated with selling and supporting this equipment" sales staff? A one off cash payment of circa £0.2m in 2H but reduction of £0.4m revenue and associated GM for future years. As I said on the 27th Aug - Business sadly appears to be in terminal decline and will struggle against well funded and much larger competitors even if Deltex have the best product? imo imo dyor DJT
dj trading
23/9/2019
08:11
Net cash generated from operations of £0.3m is an excellent result and clearly shows the cash position improving. You would expect them to have increased stocks in first half because sales are always stronger in second half. You would expect them to reduce debtors in first half because they are collecting the cash from the stronger second half sales You are being unduly negative about profitability. Being EBITDA positive is a major milestone in itself, but you need to look also at the operating loss before exceptional line. H1 was £0.2m down £0.9m from £1.1m in 2018 which is a dramatic improvement. BUT second half last year was already profitable by £0.1m pre exceptionals so that is an operating loss of less than £0.1m over the last 12 months. At worst you can say this is now break-even and well on track to be profitable for the year and that is very good news especially when added to it being cash positive
schloo
Chat Pages: 835  834  833  832  831  830  829  828  827  826  825  824  Older
Your Recent History
LSE
DEMG
Deltex Med..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20191215 23:46:29